rhfgf basic protein Search Results


92
R&D Systems recombinant human fgf basic rhfgfb
Recombinant Human Fgf Basic Rhfgfb, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human fgf basic rhfgfb/product/R&D Systems
Average 92 stars, based on 1 article reviews
recombinant human fgf basic rhfgfb - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier

95
R&D Systems rhfgf basic protein
Rhfgf Basic Protein, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhfgf basic protein/product/R&D Systems
Average 95 stars, based on 1 article reviews
rhfgf basic protein - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

98
R&D Systems rhfgf2
Rhfgf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rhfgf2/product/R&D Systems
Average 98 stars, based on 1 article reviews
rhfgf2 - by Bioz Stars, 2026-03
98/100 stars
  Buy from Supplier

94
R&D Systems recombinant human basic fibroblast growth factor
Recombinant Human Basic Fibroblast Growth Factor, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human basic fibroblast growth factor/product/R&D Systems
Average 94 stars, based on 1 article reviews
recombinant human basic fibroblast growth factor - by Bioz Stars, 2026-03
94/100 stars
  Buy from Supplier

90
Promega fibroblast growth factor, basic, human, recombinant (rhfgf, basic)
Fibroblast Growth Factor, Basic, Human, Recombinant (Rhfgf, Basic), supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fibroblast growth factor, basic, human, recombinant (rhfgf, basic)/product/Promega
Average 90 stars, based on 1 article reviews
fibroblast growth factor, basic, human, recombinant (rhfgf, basic) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

95
R&D Systems recombinant human fibroblast growth factor 2 rhfgf2
Recombinant Human Fibroblast Growth Factor 2 Rhfgf2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human fibroblast growth factor 2 rhfgf2/product/R&D Systems
Average 95 stars, based on 1 article reviews
recombinant human fibroblast growth factor 2 rhfgf2 - by Bioz Stars, 2026-03
95/100 stars
  Buy from Supplier

99
R&D Systems recombinant human fgf 2
Recombinant Human Fgf 2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human fgf 2/product/R&D Systems
Average 99 stars, based on 1 article reviews
recombinant human fgf 2 - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
PeproTech recombinant human fibroblast growth factor-2 (rhfgf-2
Recombinant Human Fibroblast Growth Factor 2 (Rhfgf 2, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human fibroblast growth factor-2 (rhfgf-2/product/PeproTech
Average 90 stars, based on 1 article reviews
recombinant human fibroblast growth factor-2 (rhfgf-2 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
NatuTec Inc recombinant human basic fibroblastic growth factor (rhfgf-2)
Recombinant Human Basic Fibroblastic Growth Factor (Rhfgf 2), supplied by NatuTec Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human basic fibroblastic growth factor (rhfgf-2)/product/NatuTec Inc
Average 90 stars, based on 1 article reviews
recombinant human basic fibroblastic growth factor (rhfgf-2) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
PeproTech recombinant human basic fibroblast growth factor
Recombinant Human Basic Fibroblast Growth Factor, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/recombinant human basic fibroblast growth factor/product/PeproTech
Average 90 stars, based on 1 article reviews
recombinant human basic fibroblast growth factor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

91
R&D Systems human basic fgf
A: Representative Northern blot analysis demonstrating an increase in TGF-β1 mRNA expression in RNA isolated from vehicle and AdCALacZ-infected NRCs in response to a 6-hour stimulation with <t>FGF-2</t> (10 ng/ml). This increase in TGF-β1 mRNA in response to FGF-2 was not seen in NRCs infected with AdCAFGF-TR. A similar pattern of TGF-β1 mRNA expression was seen in PFDCs after infection and stimulation (data not shown). 50 = 50 plaque forming units/cell; 100 = 100 plaque forming units/cell. B: Representative Northern blot analysis demonstrating an increase in collagen type I mRNA expression in RNA isolated from vehicle and AdCALacZ-infected PFDCs in response to 48-hour stimulation with FGF-2 (10 ng/ml). PFDCs infected with AdCAFGF-TR failed to demonstrate an increase in collagen type I mRNA. Interestingly, infected NRCs did not demonstrate differences in collagen type I gene expression in response to FGF-2 (data not shown). C: Cells infected with AdCAFGF-TR proliferated significantly slower than cells infected with vehicle and AdCALacZ. Graphic representation of BrdU incorporation by NRCs infected with vehicle, AdCALacZ, or AdCAFGF-TR. Note statistically significant decreased proliferation in NRCs infected with AdCAFGF-TR (*, P < 0.001). All cells were stimulated <t>with</t> <t>rhFGF-2.</t> D: Results of proliferation assay. Note significantly decreased proliferation of NRCs infected with AdCAFGF-TR (*, P < 0.001). All cells were stimulated with rhFGF-2. E: Representative Northern blot analysis demonstrating an increase in baseline TGF-β1 mRNA expression in RNA isolated from AdCAsFGF-2-infected NRCs. Similar pattern of TGF-β1 mRNA expression was seen in PFDCs after AdCAsFGF-2 infection (data not shown). F: Cells infected with AdCAsFGF-2 proliferated significantly faster than cells infected with vehicle and AdCALacZ. Graphic representation of BrdU incorporation by NRCs infected with vehicle, AdCALacZ, or AdCAsFGF-2. Note statistically significantly increased proliferation in NRCs infected with AdCAsFGF-2. (*, P < 0.001). G: Results of proliferation assay. Note significantly increased proliferation of NRCs infected with AdCAsFGF-2 (*, P < 0.001).
Human Basic Fgf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human basic fgf/product/R&D Systems
Average 91 stars, based on 1 article reviews
human basic fgf - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier

Image Search Results


A: Representative Northern blot analysis demonstrating an increase in TGF-β1 mRNA expression in RNA isolated from vehicle and AdCALacZ-infected NRCs in response to a 6-hour stimulation with FGF-2 (10 ng/ml). This increase in TGF-β1 mRNA in response to FGF-2 was not seen in NRCs infected with AdCAFGF-TR. A similar pattern of TGF-β1 mRNA expression was seen in PFDCs after infection and stimulation (data not shown). 50 = 50 plaque forming units/cell; 100 = 100 plaque forming units/cell. B: Representative Northern blot analysis demonstrating an increase in collagen type I mRNA expression in RNA isolated from vehicle and AdCALacZ-infected PFDCs in response to 48-hour stimulation with FGF-2 (10 ng/ml). PFDCs infected with AdCAFGF-TR failed to demonstrate an increase in collagen type I mRNA. Interestingly, infected NRCs did not demonstrate differences in collagen type I gene expression in response to FGF-2 (data not shown). C: Cells infected with AdCAFGF-TR proliferated significantly slower than cells infected with vehicle and AdCALacZ. Graphic representation of BrdU incorporation by NRCs infected with vehicle, AdCALacZ, or AdCAFGF-TR. Note statistically significant decreased proliferation in NRCs infected with AdCAFGF-TR (*, P < 0.001). All cells were stimulated with rhFGF-2. D: Results of proliferation assay. Note significantly decreased proliferation of NRCs infected with AdCAFGF-TR (*, P < 0.001). All cells were stimulated with rhFGF-2. E: Representative Northern blot analysis demonstrating an increase in baseline TGF-β1 mRNA expression in RNA isolated from AdCAsFGF-2-infected NRCs. Similar pattern of TGF-β1 mRNA expression was seen in PFDCs after AdCAsFGF-2 infection (data not shown). F: Cells infected with AdCAsFGF-2 proliferated significantly faster than cells infected with vehicle and AdCALacZ. Graphic representation of BrdU incorporation by NRCs infected with vehicle, AdCALacZ, or AdCAsFGF-2. Note statistically significantly increased proliferation in NRCs infected with AdCAsFGF-2. (*, P < 0.001). G: Results of proliferation assay. Note significantly increased proliferation of NRCs infected with AdCAsFGF-2 (*, P < 0.001).

Journal:

Article Title: In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate

doi:

Figure Lengend Snippet: A: Representative Northern blot analysis demonstrating an increase in TGF-β1 mRNA expression in RNA isolated from vehicle and AdCALacZ-infected NRCs in response to a 6-hour stimulation with FGF-2 (10 ng/ml). This increase in TGF-β1 mRNA in response to FGF-2 was not seen in NRCs infected with AdCAFGF-TR. A similar pattern of TGF-β1 mRNA expression was seen in PFDCs after infection and stimulation (data not shown). 50 = 50 plaque forming units/cell; 100 = 100 plaque forming units/cell. B: Representative Northern blot analysis demonstrating an increase in collagen type I mRNA expression in RNA isolated from vehicle and AdCALacZ-infected PFDCs in response to 48-hour stimulation with FGF-2 (10 ng/ml). PFDCs infected with AdCAFGF-TR failed to demonstrate an increase in collagen type I mRNA. Interestingly, infected NRCs did not demonstrate differences in collagen type I gene expression in response to FGF-2 (data not shown). C: Cells infected with AdCAFGF-TR proliferated significantly slower than cells infected with vehicle and AdCALacZ. Graphic representation of BrdU incorporation by NRCs infected with vehicle, AdCALacZ, or AdCAFGF-TR. Note statistically significant decreased proliferation in NRCs infected with AdCAFGF-TR (*, P < 0.001). All cells were stimulated with rhFGF-2. D: Results of proliferation assay. Note significantly decreased proliferation of NRCs infected with AdCAFGF-TR (*, P < 0.001). All cells were stimulated with rhFGF-2. E: Representative Northern blot analysis demonstrating an increase in baseline TGF-β1 mRNA expression in RNA isolated from AdCAsFGF-2-infected NRCs. Similar pattern of TGF-β1 mRNA expression was seen in PFDCs after AdCAsFGF-2 infection (data not shown). F: Cells infected with AdCAsFGF-2 proliferated significantly faster than cells infected with vehicle and AdCALacZ. Graphic representation of BrdU incorporation by NRCs infected with vehicle, AdCALacZ, or AdCAsFGF-2. Note statistically significantly increased proliferation in NRCs infected with AdCAsFGF-2. (*, P < 0.001). G: Results of proliferation assay. Note significantly increased proliferation of NRCs infected with AdCAsFGF-2 (*, P < 0.001).

Article Snippet: After 24 hours (ie, 48 hours after infection), 10 ng/ml of recombinant human basic FGF (rhFGF-2; R&D Systems, Minneapolis, MN) was added to the serum-free media.

Techniques: Northern Blot, Expressing, Isolation, Infection, Gene Expression, BrdU Incorporation Assay, Proliferation Assay

A: Northern (left) and Western blot (right) analysis demonstrating high-level expression of FGF-TR. Note increase in FGF-TR mRNA and protein with increasing plaque-forming units. Compare AdCAFGF-TR 50 with AdCAFGF-TR 100. 50 = 50 plaque-forming units/cell; 100 = 100 plaque-forming units/cell. B: Western blot analysis demonstrating increased phosphorylation of ERK-1 and -2 after FGF-2 stimulation (+) in vehicle and AdCALacZ-infected NRCs (top immunoblot). In contrast, AdCAFGF-TR-infected NRCs demonstrate no increase in ERK-1 and -2 phosphorylation in response to rhFGF-2 stimulation. Total ERK-2 immunoblot of same blot (bottom immunoblot) demonstrating presence of similar levels of unphosphorylated protein in all lanes. C: Western blot analysis for FGF-2 demonstrates increased expression of FGF-2 protein in NRCs infected with AdCsFGF-2. D: Western blot analysis demonstrating increased phosphorylation of ERK-1 and -2 after AdCAsFGF-2 infection of NRCs (top immunoblot). Total ERK-1 and -2 immunoblot of same membrane (bottom immunoblot) demonstrating presence of similar levels of unphosphorylated protein in all lanes. In this experiment, cells were maintained in serum-free media without the addition of rhFGF-2.

Journal:

Article Title: In Vivo Modulation of FGF Biological Activity Alters Cranial Suture Fate

doi:

Figure Lengend Snippet: A: Northern (left) and Western blot (right) analysis demonstrating high-level expression of FGF-TR. Note increase in FGF-TR mRNA and protein with increasing plaque-forming units. Compare AdCAFGF-TR 50 with AdCAFGF-TR 100. 50 = 50 plaque-forming units/cell; 100 = 100 plaque-forming units/cell. B: Western blot analysis demonstrating increased phosphorylation of ERK-1 and -2 after FGF-2 stimulation (+) in vehicle and AdCALacZ-infected NRCs (top immunoblot). In contrast, AdCAFGF-TR-infected NRCs demonstrate no increase in ERK-1 and -2 phosphorylation in response to rhFGF-2 stimulation. Total ERK-2 immunoblot of same blot (bottom immunoblot) demonstrating presence of similar levels of unphosphorylated protein in all lanes. C: Western blot analysis for FGF-2 demonstrates increased expression of FGF-2 protein in NRCs infected with AdCsFGF-2. D: Western blot analysis demonstrating increased phosphorylation of ERK-1 and -2 after AdCAsFGF-2 infection of NRCs (top immunoblot). Total ERK-1 and -2 immunoblot of same membrane (bottom immunoblot) demonstrating presence of similar levels of unphosphorylated protein in all lanes. In this experiment, cells were maintained in serum-free media without the addition of rhFGF-2.

Article Snippet: After 24 hours (ie, 48 hours after infection), 10 ng/ml of recombinant human basic FGF (rhFGF-2; R&D Systems, Minneapolis, MN) was added to the serum-free media.

Techniques: Northern Blot, Western Blot, Expressing, Phospho-proteomics, Infection, Membrane